Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
214,467,875
-
Total 13F shares
-
10,685,998
-
Share change
-
+5,679,252
-
Total reported value
-
$448,639,275
-
Price per share
-
$41.98
-
Number of holders
-
56
-
Value change
-
+$240,805,053
-
Number of buys
-
43
-
Number of sells
-
12
Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q1 2015
As of 31 Mar 2015,
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,685,998 shares.
The largest 10 holders included
Capital Research Global Investors, Polaris Venture Management Co. V, L.L.C., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, Lamond Capital Partners LLC, RS INVESTMENT MANAGEMENT CO LLC, FEDERATED INVESTORS INC /PA/, Ballentine Partners, LLC, and Pentwater Capital Management LP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.